351 related articles for article (PubMed ID: 17182759)
1. Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors.
Tsigrelis C; Singh KV; Coutinho TD; Murray BE; Baddour LM
J Clin Microbiol; 2007 Feb; 45(2):631-5. PubMed ID: 17182759
[TBL] [Abstract][Full Text] [Related]
2. Short-term success, but long-term treatment failure with linezolid for enterococcal endocarditis.
Berdal JE; Eskesen A
Scand J Infect Dis; 2008; 40(9):765-6. PubMed ID: 18609208
[TBL] [Abstract][Full Text] [Related]
3. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
[TBL] [Abstract][Full Text] [Related]
5. [Linezolid therapy for infectious endocarditis].
Lauridsen TK; Arpi M; Bruun NE
Ugeskr Laeger; 2010 Apr; 172(16):1215-6. PubMed ID: 20423667
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection.
Archuleta S; Murphy B; Keller MJ
Transpl Infect Dis; 2004 Sep; 6(3):117-9. PubMed ID: 15569227
[TBL] [Abstract][Full Text] [Related]
7. Failure of linezolid treatment for enterococcal endocarditis.
Zimmer SM; Caliendo AM; Thigpen MC; Somani J
Clin Infect Dis; 2003 Aug; 37(3):e29-30. PubMed ID: 12884185
[TBL] [Abstract][Full Text] [Related]
8. Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.
Moreillon P; Wilson WR; Leclercq R; Entenza JM
Antimicrob Agents Chemother; 2007 May; 51(5):1661-5. PubMed ID: 17353251
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
Dowzicky MJ
Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin-resistant VanA phenotype Enterococcus faecalis: first case in Minas Gerais state and epidemiological considerations.
Ribas RM; Darini AL; Moreira TA; Freitas C; Gontijo Filho PP
Braz J Infect Dis; 2007 Aug; 11(4):439-40. PubMed ID: 17874002
[TBL] [Abstract][Full Text] [Related]
11. Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature.
Jasovich A; Ganaha MC; Ebi C; García RD; Blanco MA; Lopardo H
Rev Argent Microbiol; 2008; 40(4):204-7. PubMed ID: 19213241
[TBL] [Abstract][Full Text] [Related]
12. Topical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis.
Tu EY; Jain S
Am J Ophthalmol; 2013 Jun; 155(6):1095-1098.e1. PubMed ID: 23453280
[TBL] [Abstract][Full Text] [Related]
13. Virulence and antibiotic resistance of Enterococcus faecalis clinical isolates recovered from three states of Mexico. Detection of linezolid resistance.
López-Salas P; Llaca-Díaz J; Morfin-Otero R; Tinoco JC; Rodriguez-Noriega E; Salcido-Gutierres L; González GM; Mendoza-Olazarán S; Garza-González E
Arch Med Res; 2013 Aug; 44(6):422-8. PubMed ID: 23973462
[TBL] [Abstract][Full Text] [Related]
14. Linezolid therapy for infective endocarditis.
Muñoz P; Rodríguez-Creixéms M; Moreno M; Marín M; Ramallo V; Bouza E; Game Study Group
Clin Microbiol Infect; 2007 Feb; 13(2):211-215. PubMed ID: 17328738
[TBL] [Abstract][Full Text] [Related]
15. Enterococcus faecalis resistant to linezolid: case series and review of the literature.
Burleson BS; Ritchie DJ; Micek ST; Dunne WM
Pharmacotherapy; 2004 Sep; 24(9):1225-31. PubMed ID: 15460184
[TBL] [Abstract][Full Text] [Related]
16. In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and vancomycin.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Ge Y; Biek D; Batard E; Potel G
Antimicrob Agents Chemother; 2009 Dec; 53(12):5300-2. PubMed ID: 19752276
[TBL] [Abstract][Full Text] [Related]
17. Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis.
Patel R; Rouse MS; Piper KE; Steckelberg JM
Antimicrob Agents Chemother; 2001 Feb; 45(2):621-3. PubMed ID: 11158767
[TBL] [Abstract][Full Text] [Related]
18. Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
Jenkins I
J Hosp Med; 2007 Sep; 2(5):343-4. PubMed ID: 17935250
[No Abstract] [Full Text] [Related]
19. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924
[TBL] [Abstract][Full Text] [Related]
20. Hospital-acquired vancomycin-resistant enterococci: now appearing in Kuala Lumpur Hospital.
Zubaidah AW; Ariza A; Azmi S
Med J Malaysia; 2006 Oct; 61(4):487-9. PubMed ID: 17243529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
